News COSMOS Pharmaceutical Corporation

Stocks

3349

JP3298400007

Drug Retailers

Market Closed - Japan Exchange Other stock markets 02:30:00 2026-07-27 EDT			5-day change	1st Jan Change
6,385.00 ^JPY	+2.39%		-0.98%	-19.61%

07-13	COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2027	CI
07-13	COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of the Fiscal Year Ending May 31, 2027	CI

All News

Mentions Relevance

07-13	COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2027	CI
07-13	COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of the Fiscal Year Ending May 31, 2027	CI
07-13	Cosmos Pharmaceutical Corporation Announces Dividend for the Fiscal Year Ended May 31, 2026, Payable on August 10, 2026; Provides Dividend Guidance for the Second Quarter-End of the Fiscal Year Ending May 31, 2027	CI
07-13	COSMOS Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended May 31, 2026	CI
04-13	Cosmos Pharmaceutical's Nine-Month Profit Rises 1.8%	MT
04-13	Cosmos Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Full Year of Fiscal Year Ending May 31, 2026	CI
04-13	COSMOS Pharmaceutical Corporation Reports Earnings Results for the Nine Months Ended February 28, 2026	CI
01-13	Cosmos Pharmaceutical's Attributable Profit Up 1.5% in Fiscal H1	MT
01-13	Cosmos Pharmaceutical Corporation Announces Dividend for the Second Quarter-End of the Fiscal Year Ending May 31, 2026, Payable on February 12, 2026	CI
25-10-14	Cosmos Pharmaceutical's Attributable Profit Up 0.3% in Fiscal Q1	MT
25-08-27	Cosmos Pharma Weighs Cutting Investment Unit to Boost Liquidity	MT
25-07-11	Cosmos Pharmaceutical's Full-Year Profit Climbs 27%	MT
25-07-11	COSMOS Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended May 31, 2025	CI
25-07-11	COSMOS Pharmaceutical Corporation Announces Year-End Dividend for the Fiscal Year Ended May 31, 2025, Payable on August 4, 2025	CI
25-07-11	COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Second Quarter-End of Fiscal Year Ending May 31, 2026	CI
25-07-11	COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2026	CI
25-07-11	COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2026	CI
25-05-09	Macquarie Downgrades Cosmos Pharmaceutical to Underperform from Neutral; Price Target is 8,000 Yen	MT
25-01-15	Cosmos Pharmaceutical's Attributable Profit Jumps 25% in Fiscal H1	MT
25-01-14	Cosmos Pharmaceutical's Attributable Profit Jumps 25% in Fiscal H1; Shares Rise 6%	MT
25-01-10	Cosmos Pharmaceutical Corporation Announces Dividend for the Second Quarter-End of Fiscal Year Ending May 31, 2025, Payable on February 12, 2025	CI
24-11-12	Jefferies Adjusts Cosmos Pharmaceutical's Price Target to 8,300 Yen From 7,900 Yen, Keeps at Buy	MT
24-10-11	Cosmos Pharmaceutical's Profit Swells 25% in Fiscal Q1	MT
24-07-12	COSMOS Pharmaceutical's Attributable Profit Gains Nearly 3% in Fiscal 2024	MT
24-07-12	COSMOS Pharmaceutical Corporation Announces Year-End Dividend for the Fiscal Year Ended May 31, 2024, Payable on August 1, 2024; Provides Second Quarter End and Year End Dividend Guidance for the Fiscal Year Ending May 31, 2025	CI